Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease.
Gord Blackhouse , Nazila Assasi , Feng Xie , John Marshall
Journal of Crohn's and Colitis 6 ( 1) 77 -85
30
2012
A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water
Amit X Garg , John Marshall , Marina Salvadori , Heather R Thiessen-Philbrook
Journal of Clinical Epidemiology 59 ( 4) 421 -428
35
2006
A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes
Mehran Anvari , Christopher Allen , John Marshall , David Armstrong
Surgical Endoscopy 25 ( 8) 2547 -2554
66
2011
Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn
Ron Goeree , Bernie J. O'Brien , Gordon Blackhouse , John Marshall
Value in Health 5 ( 4) 312 -328
28
2002
A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastroesophageal Reflux Disease: One-Year Follow-Up
Mehran Anvari , Christopher Allen , John Marshall , David Armstrong
Surgical Innovation 13 ( 4) 238 -249
101
2006
The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease
Richard N. Fedorak , Brian G. Feagan , Naomi Hotte , Des Leddin
Clinical Gastroenterology and Hepatology 13 ( 5) 928 -935.e2
102
2015
Use of a national endoscopic database to determine the adoption of emerging pharmacological and endoscopic technologies in the every day care of patients with upper GI bleeding: the RUGBE initiative
Alan N Barkun , Naoki Chiba , Rob Enns , John Marshall
The American Journal of Gastroenterology 96 ( 9) S261
21
2001
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery
J. K. Marshall , M. Thabane , A. X. Garg , W. F. Clark
Gut 59 ( 5) 605 -611
169
2010
Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario
J. K. Marshall , M. Thabane , A. X. Garg , W. Clark
Alimentary Pharmacology & Therapeutics 20 1317 -1322
240
2004
A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract.
J. K. Marshall , K. D. Rainsford , C. James , R. H. Hunt
Alimentary Pharmacology & Therapeutics 14 ( 11) 1451 -1457
52
2000
Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy
S. Gandhi , N. Narula , W. Mosleh , J. K. Marshall
Alimentary Pharmacology & Therapeutics 37 ( 10) 947 -952
48
2013
Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease
N. Narula , D. Charleton , J. K. Marshall
Alimentary Pharmacology & Therapeutics 37 ( 11) 1057 -1064
116
2013
LDP-02 (Millenium).
J K Marshall
Current opinion in investigational drugs 2 ( 4) 502 -504
10
2001
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.
J K Marshall , E J Irvine
Gut 40 ( 6) 775 -781
253
1997
Systematic review and meta‐analysis: the incidence and prognosis of post‐infectious irritable bowel syndrome
M. THABANE , D. T. KOTTACHCHI , J. K. MARSHALL
Alimentary Pharmacology & Therapeutics 26 ( 4) 535 -544
370
2007
Environment and epidemiology of inflammatory bowel disease
J Marchal , R Hilsden
Inflammatory bowel disease. Ed. Satsangi J, Sutherland L–Churchill-Livingstone.–2003.–17-28
33
2003